Uriti Sri Venkatesh

Mr. Uriti Sri Venkatesh

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2025 in Gels
Verified
Journal Article
Open access
PDF file
Koushik YetukuriKoushik Yetukuri
Koushik Yetukuri
RNRama Rao Nadendla
Rama Rao Nadendla
Uriti Sri VenkateshUriti Sri Venkatesh
Uriti Sri Venkatesh
VRVenkata Rami Reddy
Venkata Rami Reddy
SVSurendra Venkata
Surendra Venkata
Sreenu ThallaSreenu Thalla
Sreenu Thalla
This study reports the development and optimization of a Melissa officinalis oil-based nanoemulgel for transdermal delivery using a Design-of-Experiments (DoE) approach. A Central Composite Design (CCD) was applied to optimize Tween 80 concentration and homogenization time, resulting in a nanoemulsion with a droplet size of 127.31 nm, PDI of 17.7%, and zeta potential of −25.0 mV, indicating good colloidal stability. FTIR analysis confirmed the presence of functional groups such as O–H, C=O, and C–O–C, supporting the oil’s phytochemical richness and therapeutic potential. DSC analysis revealed enhanced thermal stability and successful encapsulation, while SEM imaging showed a uniform and spherical microstructure. The drug release followed Higuchi kinetics (R2 = 0.900), indicating diffusion-driven release, with the Korsmeyer–Peppas model (n = 0.88) suggesting anomalous transport. Antibacterial studies showed inhibition of Staphylococcus aureus (MIC = 250 µg/mL) and Escherichia coli (MIC = 500 µg/mL). In vivo anti-inflammatory testing demonstrated significant edema reduction (p < 0.05) using a carrageenan-induced rat paw model. These results support the potential of Melissa nanoemulgel as a stable and effective topical therapeutic for inflammatory and microbial skin disorders.

9 June 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Koushik YetukuriKoushik Yetukuri
Koushik Yetukuri
RNRama Rao Nadendla
Rama Rao Nadendla
Uriti Sri VenkateshUriti Sri Venkatesh
Uriti Sri Venkatesh
VRVenkata Rami Reddy
Venkata Rami Reddy
SVSurendra Venkata
Surendra Venkata
Sreenu ThallaSreenu Thalla
Sreenu Thalla
This research explores the use of a Design of Experiments (DoE) framework for the development and systematic refinement of a nanoemulsion comprising Melissa officinalis essential oil for transdermal drug delivery applications. Fourier-transform infrared spectroscopy (FTIR) confirmed the presence of characteristic phytochemical groups such as hydroxyl (–OH), carbonyl (C=O), and ether (C–O–C), pointing to the oil’s phytochemical makeup. To examine the effect of various formulation factors, a Central Composite Design (CCD) was implemented. This strategy aimed to minimize droplet size and enhance emulsion stability by evaluating the influence of Tween 80 concentration and homogenization time. The optimized formulation resulted in an average droplet diameter of 127.31 nm, a polydispersity index of 17.7%, 88.3% transmittance, and a zeta potential of –25.0 mV, indicating favorable colloidal stability and uniformity. The drug release study revealed that the release pattern adhered to the Higuchi model (R² = 0.900; k = 4.63), which suggests a diffusion-driven mechanism. Further kinetic analysis based on the Korsmeyer–Peppas equation (n = 0.88) indicated a non-Fickian, or anomalous, release behavior. In vitro antimicrobial testing showed that Staphylococcus aureus (MIC = 250 µg/mL) was more sensitive to the formulation compared to Escherichia coli (MIC = 500 µg/mL). Evaluation of anti-inflammatory efficacy in vivo, using a carrageenan-induced paw edema model, showed that the formulation significantly decreased inflammation (p = 0.005 at 60 minutes), with full reduction by 240 minutes. These outcomes highlight the therapeutic value of Melissa officinalis oil-based nanoemulgel as a promising carrier for transdermal management of microbial infections and inflammatory conditions.

21 February 2025 in Current Pharmaceutical Letters And Reviews
Verified
Journal Article
Open access
PDF file
MJM. Jasvitha
M. Jasvitha
SSS S.Swapna
S S.Swapna
DSD.T. Sakhare
D.T. Sakhare
Uriti Sri VenkateshUriti Sri Venkatesh
Uriti Sri Venkatesh
The present study focuses on the formulation and in-vitro evaluation of mucoadhesive ocular inserts containing Sulfacetamide Sodium, a broad-spectrum antibiotic widely used for treating bacterial conjunctivitis and other ocular infections. Conventional eye drops suffer from poor bioavailability and rapid precorneal elimination, requiring frequent administration. To overcome these limitations, five formulations (F1–F5) were prepared using hydrophilic polymers—hydroxypropyl methylcellulose (HPMC), sodium alginate, and chitosan—via solvent casting technique. The inserts were evaluated for physicochemical properties, drug content, swelling index, tensile strength, in-vitro drug release, ex-vivo mucoadhesion, and sterility. Among all, formulation F2 demonstrated optimal performance with a thickness of 0.224 mm, surface pH of 7.02, and drug content of 99.3%. It exhibited sustained drug release over 12 hours (94.2%), following Higuchi diffusion kinetics. F2 also showed the highest mucoadhesive strength (15.3 g) and longest ocular retention (94 min). Histopathological evaluation confirmed no tissue damage, and all formulations passed sterility tests. The results confirm that mucoadhesive ocular inserts are a safe, effective, and patient-compliant alternative to conventional eye drops for ocular drug delivery, offering prolonged drug retention and improved therapeutic efficacy.

24 July 2025 in International Journal of Pharmacognosy and Herbal Drug Technology
Verified
Journal Article
Open access
PDF file
Uriti Sri VenkateshUriti Sri Venkatesh
Uriti Sri Venkatesh
Tinospora cordifolia (Willd.) Miers is a common medicinal plant used in Ayurvedic medicine from which we have previously shown promising anti-inflammatory properties can be attributed to alkaloids in the plant. The objective of our study was to isolate and characterize anti-inflammatory alkaloids from this plant through guided bioassay fractionation and isolation of the methanolic stem extract. Methanolic extract was fractionated into hexane, chloroform, ethyl acetate, and aqueous extracts sequentially. We evaluated the extracts for inhibition of nitric oxide (NO) in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. The best extracts underwent chromatographic purifications and active compounds were identified using NMR and LC-MS. Two alkaloids decreased NO formation with an IC₅₀ of 18.3 µg/mL and 21.6 µg/mL with little if any cytotoxic activity. These data support the therapeutic application of selected T. cordifolia alkaloids as natural anti-inflammatory compounds and warrant pharmacological development.

21 February 2025 in Current Pharmaceutical Letters And Reviews
Verified
Journal Article
Open access
PDF file
NINisha
Nisha
SKShereen Khan
Shereen Khan
KCKpurna Chander
Kpurna Chander
Uriti Sri VenkateshUriti Sri Venkatesh
Uriti Sri Venkatesh
This study focuses on the formulation and characterization of Stimuli-Responsive Injectable Polymeric Implants (SIPI) for long-term drug release in chronic disease management. Chronic conditions such as diabetes, cardiovascular disorders, and neurodegenerative diseases require continuous therapeutic delivery, which traditional methods often fail to sustain due to poor compliance and fluctuating drug levels. SIPI systems offer an innovative solution by utilizing biodegradable polymers that respond to physiological stimuli—such as pH and temperature—to modulate drug release. Four formulations were developed using PLGA, PCL, Chitosan, and a PLGA-Chitosan blend. These were evaluated for physicochemical properties, thermal stability, surface morphology, biodegradation, and drug release kinetics. The PLGA-Chitosan formulation (F4) exhibited optimal performance, balancing mechanical strength, degradation rate, and controlled drug release. In-vitro studies confirmed biphasic release profiles and diffusion-controlled mechanisms as per Korsmeyer-Peppas and Higuchi models. Analytical techniques including FTIR, DSC, SEM, and HPLC validated structural compatibility and performance stability. Overall, SIPI-based implants demonstrate promising potential for site-specific, long-term drug delivery in chronic disease therapy. The results support further in-vivo investigations and clinical development of smart, patient-compliant drug delivery platforms designed to enhance therapeutic efficacy and improve quality of life in long-term treatment scenarios.

4 May 2026 in Journal of Diversity Studies
Verified
Journal Article
Closed access
Uriti Sri VenkateshUriti Sri Venkatesh
Uriti Sri Venkatesh
AMAcharyulu Mln
Acharyulu Mln
PGPattnaik Gurudatta
Pattnaik Gurudatta
Pharmaceutical residues in terrestrial ecosystems pose physiological challenges to wild mammalian fauna. The co-occurrence of cardiovascular modulators, such as the hyperpolarization-activated cyclic nucleotide-gated (If) channel blocker ivabradine, alongside oral hypoglycemic agents like metformin in habitats alters the metabolic and cardiovascular homeostatic mechanisms of non-target species. Wild rodent populations, particularly within the family Muridae, frequently inhabit anthropogenically impacted zones where they ingest bioaccumulative xenobiotics through contaminated food and water sources. Laboratory baselines, specifically streptozotocin-induced diabetic rodent models, show that metabolic dysfunction induces profound myocardial and vascular remodeling, characterized by autonomic imbalance and accelerated oxidative stress. The concurrent administration of ivabradine and antidiabetic agents in controlled cohorts mitigates heart rate elevation, preserves endothelial integrity, and normalizes glycemic fluctuations. Translating these pharmacological synergies to wild populations requires a multi-trophic perspective. Chronic exposure to sublethal therapeutic mixtures in natural environments perturbs natural adaptive thermogenesis, foraging behaviors, and predator-avoidance responses of wild rodents. The physiological alterations observed in laboratory trials serve as a predictive matrix for assessing ecological risk. Evaluating these mammalian responses at the individual and population levels reveals how chronic xenobiotic exposure compromises wildlife fitness and ecosystem-level resilience.